微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 61.17% | -9.13% | -11.03% | 3/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 68.75% | 3.3% | 0.82% | 1/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 68.19% | 3.8% | 4.07% | 1/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 65.53% | -2.74% | -2.66% | 2/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 67.32% | -3.5% | 1.14% | 2/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 66.56% | 1.48% | 1.32% | 2/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 65.69% | -1.9% | -2.49% | 3/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 67.37% | 0.16% | -3.42% | 2/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 69.76% | 3.59% | 6.36% | 2/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 65.59% | -1.6% | -2.06% | 2/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 66.96% | 2% | -0.45% | 2/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 67.26% | 2.21% | -0.12% | 3/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 67.34% | 2% | 1.04% | 2/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 66.65% | 6.03% | 1.27% | 4/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2020-12-31 | 65.81% | 5.81% | 4.69% | 3/51 | 38.51% | 南华生物 | 83.9% | 行业排名> |
| 2020-06-30 | 62.86% | 17.36% | 1.07% | 4/51 | 39.28% | 成都先导 | 79.36% | 行业排名> |
| 2019-12-31 | 62.2% | 15.1% | 15.1% | 5/51 | 42.94% | 成都先导 | 75.92% | 行业排名> |
| 2018-12-31 | 54.04% | 36.01% | 36.01% | 7/51 | 42.09% | 南华生物 | 78.74% | 行业排名> |
| 2017-12-31 | 39.73% | 2% | -25.82% | 24/51 | 40.94% | 成都先导 | 80.82% | 行业排名> |
| 2017-06-30 | 53.56% | 2% | 2% | 8/51 | 43.6% | 成都先导 | 81.55% | 行业排名> |